Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reduced Nicotine Cigarette Purchasing Decisions
NCT04999644Phase 1Completed
- Sponsor
- Johns Hopkins University
- Start
- Feb 2022
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of nicotine in Tobacco Use Disorder (TUD) (4 arms), sponsored by Johns Hopkins University. Primary endpoints: Demand Intensity at 2 weeks and Demand Elasticity at 2 weeks. Started Feb 2022; status: completed.
02
Drugs
nicotine
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT04999644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04999644.